Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
11:20am, Tuesday, 17'th Jan 2023 Zacks Investment Research
Sector ETF report for IHE
Biogen (BIIB) Partner Eisai Seeks Nod for Lecanemab in Japan
05:33pm, Monday, 16'th Jan 2023 Zacks Investment Research
Biogen's (BIIB) partner Eisai files a marketing authorization application for lecanemab for treating early Alzheimer's disease in Japan.
3 Growth Stocks Poised for Huge Gains in 2023
12:50pm, Saturday, 14'th Jan 2023 The Motley Fool
These big pharmaceuticals are poised for back-to-back big years.
3 Growth Stocks Poised for Huge Gains in 2023
07:50am, Saturday, 14'th Jan 2023
These big pharmaceuticals are poised for back-to-back big years.
State of California Sues Insulin Makers for Unfair Practices
04:39pm, Friday, 13'th Jan 2023 Zacks Investment Research
The lawsuit aims to curb the skyrocketing cost of insulin charged by insulin manufacturers and pharmacy benefit managers companies. The State also seeks to recover some monetary compensation.
Top-Performing Hedge Fund In 2022 Has This Strategy To Thank: How Much Did It Make Last Year?
03:46pm, Friday, 13'th Jan 2023 Benzinga
Macro trading is an investment strategy that takes into account both domestic and global macroeconomic trends.
Most global macro trading ideas are in essence so simple that even the most inexperience
State of California Sues Insulin Makers for Unfair Practices
12:48pm, Friday, 13'th Jan 2023
The lawsuit aims to curb the skyrocketing cost of insulin charged by insulin manufacturers and pharmacy benefit managers companies. The State also seeks to recover some monetary compensation.
How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer, Eli Lilly
10:58am, Friday, 13'th Jan 2023
The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday. The post How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer,
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
10:45pm, Thursday, 12'th Jan 2023 Zacks Investment Research
Eli Lilly (LLY) closed at $359.12 in the latest trading session, marking a -0.36% move from the prior day.
California Sues Eli Lilly And Other Insulin Makers For Driving Up Drug Cost
03:58pm, Thursday, 12'th Jan 2023
California Attorney General Rob Bonta accused the drug makers of “leveraging their market power” to jack up the price of insulin.
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
02:00pm, Thursday, 12'th Jan 2023 Zacks Investment Research
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
10:32am, Thursday, 12'th Jan 2023
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
Eli Lilly Had a Strong Year in 2022. It's Expecting an Even Better 2023.
03:15pm, Wednesday, 11'th Jan 2023 The Motley Fool
The company has multiple growth catalysts on the horizon that could propel the stock this year and beyond.
Biogen's (BIIB) Partner Eisai Files MAA for Lecanemab in Europe
02:38pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
Biogen's (BIIB) partner Eisai files a marketing authorization application to the European Medicines Agency for lecanemab for treating early Alzheimer's disease in Europe.
